Optionale Produktanalyse
Mit Ihrer Erlaubnis verwenden wir datenschutzfreundliche Analysen, um zu verstehen, welche Recherchewege funktionieren. Wir verwenden weder Werbe-Tracker noch Sitzungsaufzeichnungen. Sie können diese Auswahl in den Einstellungen ändern. Lesen Sie die Datenschutzerklärung.
Republic Services, Inc.'s published Reduce conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $64.9B | |
|---|---|---|
| Revenue (ttm) | 16.9B | |
| Net income (ttm) | 2.2B | |
| EPS (ttm) | $7.06 | |
| Shares out | 306.2M | |
| P/E (trailing) | 33.1x | |
| P/E (forward) | 26.3x | |
| Dividend | $2.68 (1.15%) | |
| Volume | 1,015,214 | |
| Beta | 0.40 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $11.30B | $13.51B | $14.97B | $16.03B | $16.59B | +10.1% |
| Gross profit | $3.29B | $3.87B | $4.42B | $4.90B | $6.96B | +20.6% |
| Operating income | $2.08B | $2.39B | $2.78B | $3.20B | $3.30B | +12.3% |
| Net income | $1.29B | $1.49B | $1.73B | $2.04B | $2.14B | +13.5% |
| EPS (diluted) | $4.04 | $4.69 | $5.47 | $6.49 | $6.85 | +14.1% |
| EBITDA | $3.15B | $3.66B | $4.32B | $4.77B | $5.10B | +12.8% |
| R&D | — | — | — | — | — | — |
| SG&A | $1.20B | $1.45B | $1.61B | $1.67B | $1.71B | +9.4% |
Recent company headlines from major financial publishers.
The modal base case reflects stable top-line compounding driven by core pricing yield and disciplined cost pass-through. Consolidated revenue expands 4.14% in FY2026 to $17,278M and 4.74% in FY2027 to $18,097M, in line with management guidance. Underlying operating margins expand 60 to 70 bps in FY2026 toward 20.5%-20.8%, lifting FY2027 EPS to consensus $8.06. Synthesized intrinsic fair value centers at $178.85.
Under the bull scenario, joint-venture renewable natural gas (RNG) and polymer recovery facilities ramp ahead of schedule, producing throughput exceeding nameplate capacity. Core pricing yield sustains above 5.5% while collection volumes recover into positive territory, driving revenue growth toward 6.0%-7.0% and expanding operating margins past 21.5%. Diluted EPS accelerates toward $8.48 by FY2027, unlocking a potential valuation of $227.41.
| Ke ↓ / g → | 1.8% | 2.3% | 2.8% | 3.3% | 3.8% |
|---|---|---|---|---|---|
| 6.5% | $191 | $201 | $215 | $233 | $260 |
| 7.0% | $176 | $185 | $195 | $208 | $225 |
| 7.5% | $165 | $171 | $179 | $189 | $201 |
| 8.0% | $155 | $160 | $166 | $173 | $183 |
| 8.5% | $147 | $151 | $155 | $161 | $168 |
Upcoming earnings date and setup when available.
Das Rating, das die veröffentlichte Research-Ausgabe des jeweiligen Monats trug. Ein Rating vergleicht den Kurs zum Analysezeitpunkt mit dem Fair Value; es ist kein Nachweis, ob die Einschätzung zutraf.
| Jahr | Jan | Feb | Mär | Apr | Mai | Jun | Jul | Aug | Sep | Okt | Nov | Dez |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |